CPA
CORZ icon

Capital Performance Advisors’s Core Scientific CORZ Stock Holding History

Capital Performance Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-72
Closed -$854 – 715
2024
Q3 		$854 Buy
+72
New +$746 ﹤0.01% 1978

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $668M AUM 45.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
JCM
JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return

Capital Performance Advisors's CORZ Position: Q4 2024 in Review

Capital Performance Advisors sold out of Core Scientific (CORZ) in Q4 2024, closing a stake of 72 shares — an estimated $854 sold.

Capital Performance Advisors first reported a position in CORZ in Q3 2024 and held it in 1 quarter. The position peaked at $854 in Q3 2024. 313 funds tracked by Wall St. Rank hold CORZ as of Q4 2024.

  • Capital Performance Advisors reported no remaining Core Scientific position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 72 Core Scientific shares in Q4 2024, an estimated $854.
  • Capital Performance Advisors first reported a position in Core Scientific in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Core Scientific position peaked at $854 in Q3 2024.
  • 313 funds tracked by Wall St. Rank held Core Scientific as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.